Trial Profile
Nightly dosing of regorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colon cancer; Liver metastases
- Focus Adverse reactions
- 12 Aug 2015 New trial record